103 related articles for article (PubMed ID: 22339587)
1. The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth.
Bastek JA; Brown AG; Foreman MN; McShea MA; Anglim LM; Adamczak JE; Elovitz MA
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1762-8. PubMed ID: 22339587
[TBL] [Abstract][Full Text] [Related]
2. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
[TBL] [Abstract][Full Text] [Related]
6. sRAGE is elevated in septic patients and associated with patients outcome.
Bopp C; Hofer S; Weitz J; Bierhaus A; Nawroth PP; Martin E; Büchler MW; Weigand MA
J Surg Res; 2008 Jun; 147(1):79-83. PubMed ID: 17981300
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
8. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in recurrent pregnancy losses (RPL): possible participation of RAGE in RPL.
Ota K; Yamagishi S; Kim M; Dambaeva S; Gilman-Sachs A; Beaman K; Kwak-Kim J
Fertil Steril; 2014 Sep; 102(3):782-9. PubMed ID: 25044082
[TBL] [Abstract][Full Text] [Related]
9. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of circulating soluble RAGE in patients with severe sepsis.
Matsumoto H; Matsumoto N; Ogura H; Shimazaki J; Yamakawa K; Yamamoto K; Shimazu T
J Trauma Acute Care Surg; 2015 Jun; 78(6):1086-93; discussion 1093-4. PubMed ID: 26002402
[TBL] [Abstract][Full Text] [Related]
13. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
Myles A; Viswanath V; Singh YP; Aggarwal A
J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
[TBL] [Abstract][Full Text] [Related]
15. Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia.
Bastek JA; Srinivas SK; Sammel MD; Elovitz MA
Am J Perinatol; 2010 Feb; 27(2):163-9. PubMed ID: 19644790
[TBL] [Abstract][Full Text] [Related]
16. Periodontal disease and nitric oxide levels in low risk women with preterm labor.
Giannella L; Giulini S; Cerami LB; La Marca A; Forabosco A; Volpe A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):47-51. PubMed ID: 21621901
[TBL] [Abstract][Full Text] [Related]
17. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
19. Mannose-binding lectin serum levels in neonatal sepsis and septic shock.
Wahab Mohamed WA; Saeed MA
J Matern Fetal Neonatal Med; 2012 Apr; 25(4):411-4. PubMed ID: 21631240
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of triggering receptor expressed on myeloid cells-1 and CD64 index as markers of sepsis in preterm newborns.
Mazzucchelli I; Garofoli F; Ciardelli L; Borghesi A; Tzialla C; Di Comite A; Angelini M; Tinelli C; Merlini G; Stronati M
Pediatr Crit Care Med; 2013 Feb; 14(2):178-82. PubMed ID: 23314180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
